EFFICACY AND SAFETY OF ELUXADOLINE IN IBS-D PATIENTS WHO REPORT INADEQUATE SYMPTOM CONTROL WITH PRIOR LOPERAMIDE USE: A PHASE 4, MULTICENTER, MULTINATIONAL, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED STUDY (RELIEF)

Darren M Brenner  1     Catherine R. Gutman  2     Esther Jo  3     Steven Elmes  2    
1 Feinberg School of Medicine, Northwestern Memorial Hospital,Chicago,United States
2 Allergan plc,Madison,United States
3 Allergan plc,Irvine,United States

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing